Temat: "hemophilia A" - OpacWWW

Skocz do pozycji: 1.

Tytuł:: De Novo Noninversion Variants Implicated in Sporadic Hemophilia A: A Variant Origin and Timing Study.
Autorzy:: Chen M; Department of Genomic Medicine, Changhua Christian Hospital, Changhua 500, Taiwan.; Department of Obstetrics and Gynecology, Changhua Christian Hospital, Changhua 500, Taiwan.; Department of Medical Genetics National Taiwan University Hospital, Taipei 100, Taiwan.; Department of Obstetrics and Gynecology, National Taiwan University Hospital, Taipei 100, Taiwan.
Shen MC; Department of Laboratory Medicine, National Taiwan University Hospital, Taipei 100, Taiwan.; Department of Internal Medicine, National Taiwan University Hospital, Taipei 100, Taiwan.; Hemophilia Treatment and Thrombosis Center, Department of Internal Medicine, Changhua Christian Hospital, Changhua 500, Taiwan.
Chang SP; Department of Genomic Medicine, Changhua Christian Hospital, Changhua 500, Taiwan.
Ma GC; Department of Genomic Medicine, Changhua Christian Hospital, Changhua 500, Taiwan.
Lee DJ; Department of Genomic Medicine, Changhua Christian Hospital, Changhua 500, Taiwan.
Yan A; Department of Genomic Medicine, Changhua Christian Hospital, Changhua 500, Taiwan.; Pokaż więcej
Źródło:: International journal of molecular sciences [Int J Mol Sci] 2024 Feb 01; Vol. 25 (3). Date of Electronic Publication: 2024 Feb 01.
Typ publikacji:: Journal Article
MeSH Terms:: Hemophilia A*/genetics
Hemophilia A*/pathology
Male ; Humans ; Pedigree ; Semen ; Mutation ; Chromosome Inversion ; Factor VIII/genetics

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 2.

Tytuł:: Moderate- to vigorous-intensity physical activities for hemophilia A patients during low-dose pharmacokinetic-guided extended half-life factor VIII prophylaxis.
Autorzy:: Srichumpuang C; Division of Pediatric Hematology and Oncology, Department of Pediatrics, Faculty of Medicine, Chulalongkorn University and King Chulalongkorn Memorial Hospital, Bangkok, Thailand.; Integrative and Innovative Hematology/Oncology Research Unit, Faculty of Medicine, Chulalongkorn University and King Chulalongkorn Memorial Hospital, Bangkok, Thailand.
Rakmanotham A; Division of Pediatric Hematology and Oncology, Department of Pediatrics, Faculty of Medicine, Chulalongkorn University and King Chulalongkorn Memorial Hospital, Bangkok, Thailand.; Integrative and Innovative Hematology/Oncology Research Unit, Faculty of Medicine, Chulalongkorn University and King Chulalongkorn Memorial Hospital, Bangkok, Thailand.
Moonla C; Division of General Internal Medicine, Department of Medicine, Faculty of Medicine, Chulalongkorn University and King Chulalongkorn Memorial Hospital, Bangkok, Thailand.; Center of Excellence in Translational Hematology, Faculty of Medicine, Chulalongkorn University and King Chulalongkorn Memorial Hospital, Bangkok, Thailand.
Sosothikul D; Division of Pediatric Hematology and Oncology, Department of Pediatrics, Faculty of Medicine, Chulalongkorn University and King Chulalongkorn Memorial Hospital, Bangkok, Thailand. .; Integrative and Innovative Hematology/Oncology Research Unit, Faculty of Medicine, Chulalongkorn University and King Chulalongkorn Memorial Hospital, Bangkok, Thailand. .; Pokaż więcej
Źródło:: Orphanet journal of rare diseases [Orphanet J Rare Dis] 2024 Mar 26; Vol. 19 (1), pp. 135. Date of Electronic Publication: 2024 Mar 26.
Typ publikacji:: Journal Article
MeSH Terms:: Factor VIII*
Hemophilia A*/drug therapy
Humans ; Half-Life ; Prospective Studies ; Quality of Life ; Hemorrhage/drug therapy ; Hemarthrosis ; Exercise

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 3.

Tytuł:: Decoding the complexity of on-target integration: characterizing DNA insertions at the CRISPR-Cas9 targeted locus using nanopore sequencing.
Autorzy:: Zhao JJ; State Key Laboratory of Experimental Hematology, Haihe Laboratory of Cell Ecosystem, Institute of Hematology & Blood Diseases Hospital, National Clinical Research Center for Blood Diseases, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin, 300020, China.; Tianjin Institutes of Health Science, Tianjin, 301600, China.
Sun XY; State Key Laboratory of Experimental Hematology, Haihe Laboratory of Cell Ecosystem, Institute of Hematology & Blood Diseases Hospital, National Clinical Research Center for Blood Diseases, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin, 300020, China.; Tianjin Institutes of Health Science, Tianjin, 301600, China.
Tian SN; Tianjin Medical University, Tianjin, China.
Zhao ZZ; College of Computer Science and Technology, China University of Petroleum (East China), Qingdao, 266000, China.
Yin MD; State Key Laboratory of Experimental Hematology, Haihe Laboratory of Cell Ecosystem, Institute of Hematology & Blood Diseases Hospital, National Clinical Research Center for Blood Diseases, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin, 300020, China.; Tianjin Institutes of Health Science, Tianjin, 301600, China.
Zhao M; State Key Laboratory of Experimental Hematology, Haihe Laboratory of Cell Ecosystem, Institute of Hematology & Blood Diseases Hospital, National Clinical Research Center for Blood Diseases, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin, 300020, China.; Tianjin Institutes of Health Science, Tianjin, 301600, China.
Zhang F; State Key Laboratory of Experimental Hematology, Haihe Laboratory of Cell Ecosystem, Institute of Hematology & Blood Diseases Hospital, National Clinical Research Center for Blood Diseases, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin, 300020, China.; Tianjin Institutes of Health Science, Tianjin, 301600, China.
Li SA; State Key Laboratory of Experimental Hematology, Haihe Laboratory of Cell Ecosystem, Institute of Hematology & Blood Diseases Hospital, National Clinical Research Center for Blood Diseases, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin, 300020, China.; Tianjin Institutes of Health Science, Tianjin, 301600, China.
Yang ZX; State Key Laboratory of Experimental Hematology, Haihe Laboratory of Cell Ecosystem, Institute of Hematology & Blood Diseases Hospital, National Clinical Research Center for Blood Diseases, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin, 300020, China.; Tianjin Institutes of Health Science, Tianjin, 301600, China.
Wen W; State Key Laboratory of Experimental Hematology, Haihe Laboratory of Cell Ecosystem, Institute of Hematology & Blood Diseases Hospital, National Clinical Research Center for Blood Diseases, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin, 300020, China.; Tianjin Institutes of Health Science, Tianjin, 301600, China.
Cheng T; State Key Laboratory of Experimental Hematology, Haihe Laboratory of Cell Ecosystem, Institute of Hematology & Blood Diseases Hospital, National Clinical Research Center for Blood Diseases, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin, 300020, China.; Tianjin Institutes of Health Science, Tianjin, 301600, China.
Gong A; College of Computer Science and Technology, China University of Petroleum (East China), Qingdao, 266000, China. .
Zhang JP; State Key Laboratory of Experimental Hematology, Haihe Laboratory of Cell Ecosystem, Institute of Hematology & Blood Diseases Hospital, National Clinical Research Center for Blood Diseases, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin, 300020, China. .; Tianjin Institutes of Health Science, Tianjin, 301600, China. .
Zhang XB; State Key Laboratory of Experimental Hematology, Haihe Laboratory of Cell Ecosystem, Institute of Hematology & Blood Diseases Hospital, National Clinical Research Center for Blood Diseases, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin, 300020, China. .; Tianjin Institutes of Health Science, Tianjin, 301600, China. .; Tianjin Medical University, Tianjin, China. .; Pokaż więcej
Źródło:: BMC genomics [BMC Genomics] 2024 Feb 17; Vol. 25 (1), pp. 189. Date of Electronic Publication: 2024 Feb 17.
Typ publikacji:: Journal Article
MeSH Terms:: Hemophilia A*/genetics
Hemophilia A*/therapy
Nanopore Sequencing*
Mice ; Animals ; CRISPR-Cas Systems ; RNA, Guide, CRISPR-Cas Systems ; Gene Editing/methods ; DNA

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 4.

Tytuł:: Rifampicin-Induced Toxic Hepatitis in a Patient with Hemophilia After Chemical Synovectomy
Autorzy:: Uğur MC; İzmir Bakırçay University, Çiğli Training and Research Hospital, Clinic of Hematology, İzmir, Türkiye
Aydoğdu S; Ege University Faculty of Medicine, Department of Orthopedics and Traumatology, İzmir, Türkiye
Kaya Biçer E; Ege University Faculty of Medicine, Department of Orthopedics and Traumatology, İzmir, Türkiye
Balkan C; Ege University Faculty of Medicine, Department of Pediatric Hematology, İzmir, Türkiye
Kavaklı K; Ege University Faculty of Medicine, Department of Pediatric Hematology, İzmir, Türkiye; Pokaż więcej
Źródło:: Turkish journal of haematology : official journal of Turkish Society of Haematology [Turk J Haematol] 2024 Mar 01; Vol. 41 (1), pp. 64-65. Date of Electronic Publication: 2024 Feb 07.
Typ publikacji:: Journal Article
MeSH Terms:: Hemophilia A*/diagnosis
Humans ; Synovectomy ; Rifampin/adverse effects ; Recurrence

Czasopismo naukowe

na półce

Pełny tekst Szczegóły

Skocz do pozycji: 5.

Tytuł:: Bleeder's Femur: The Proximal Femoral Morphology in Hemophilic Patients Who Underwent Total Hip Arthroplasty.
Autorzy:: Gong Y; The First Affiliated Hospital of Zhejiang Chinese Medical University (Zhejiang Provincial Hospital of Chinese Medicine), Hangzhou, China.
Su H; The First Affiliated Hospital of Zhejiang Chinese Medical University (Zhejiang Provincial Hospital of Chinese Medicine), Hangzhou, China.
Jin Z; The First Affiliated Hospital of Zhejiang Chinese Medical University (Zhejiang Provincial Hospital of Chinese Medicine), Hangzhou, China.
Zhou H; The First Affiliated Hospital of Zhejiang Chinese Medical University (Zhejiang Provincial Hospital of Chinese Medicine), Hangzhou, China.
Chen L; The First Affiliated Hospital of Zhejiang Chinese Medical University (Zhejiang Provincial Hospital of Chinese Medicine), Hangzhou, China.
Chen R; The First Affiliated Hospital of Zhejiang Chinese Medical University (Zhejiang Provincial Hospital of Chinese Medicine), Hangzhou, China.
Tang Y; The First Affiliated Hospital of Zhejiang Chinese Medical University (Zhejiang Provincial Hospital of Chinese Medicine), Hangzhou, China.
Lu Y; The First Affiliated Hospital of Zhejiang Chinese Medical University (Zhejiang Provincial Hospital of Chinese Medicine), Hangzhou, China.
Chen J; The First Affiliated Hospital of Zhejiang Chinese Medical University (Zhejiang Provincial Hospital of Chinese Medicine), Hangzhou, China.
Chen G; The First Affiliated Hospital of Zhejiang Chinese Medical University (Zhejiang Provincial Hospital of Chinese Medicine), Hangzhou, China.
Tong P; The First Affiliated Hospital of Zhejiang Chinese Medical University (Zhejiang Provincial Hospital of Chinese Medicine), Hangzhou, China.; Pokaż więcej
Źródło:: Orthopaedic surgery [Orthop Surg] 2024 Mar; Vol. 16 (3), pp. 718-723. Date of Electronic Publication: 2024 Jan 05.
Typ publikacji:: Journal Article
MeSH Terms:: Arthroplasty, Replacement, Hip*/methods
Hemophilia A*/complications
Arthritis*/surgery
Hip Prosthesis*
Adult ; Humans ; Male ; Middle Aged ; Female ; Retrospective Studies ; Femur/diagnostic imaging ; Femur/surgery ; Femur/anatomy & histology

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 6.

Tytuł:: Barriers to gene therapy, understanding the concerns people with haemophilia have: an exigency sub-study.
Autorzy:: Fletcher S; Haemnet, London, N15 3JR, UK. .; Oxford Haemophilia and Thrombosis Centre, Oxford University Hospitals NHS Foundation Trust, Oxford, OX3 7LE, UK. .
Jenner K; Haemnet, London, N15 3JR, UK.
Holland M; Haemnet, London, N15 3JR, UK.
Khair K; Haemnet, London, N15 3JR, UK.; Pokaż więcej
Źródło:: Orphanet journal of rare diseases [Orphanet J Rare Dis] 2024 Feb 10; Vol. 19 (1), pp. 59. Date of Electronic Publication: 2024 Feb 10.
Typ publikacji:: Journal Article
MeSH Terms:: Hemophilia A*/drug therapy
Hemophilia B*
Humans ; Adult ; Middle Aged ; Aged ; Quality of Life ; Hemorrhage ; Genetic Therapy

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 7.

Tytuł:: Relapse of Acquired Hemophilia A after COVID-19 Infection.
Autorzy:: Marumo A; Division of Internal Medicine, Fussa Hospital.; Department of Hematology, Nippon Medical School.
Sugihara H; Division of Clinical Laboratory, Fussa Hospital.
Omori I; Division of Internal Medicine, Fussa Hospital.; Department of Hematology, Nippon Medical School.
Morishita E; Department of Clinical Laboratory Sciences, Institute of Medical, Pharmaceutical and Health Sciences, Faculty of Health Sciences, Kanazawa University.; Pokaż więcej
Źródło:: Journal of Nippon Medical School = Nippon Ika Daigaku zasshi [J Nippon Med Sch] 2024 Jan 20; Vol. 90 (6), pp. 474-479. Date of Electronic Publication: 2023 Feb 21.
Typ publikacji:: Case Reports; Journal Article
MeSH Terms:: COVID-19*/complications
Hemophilia A*/complications
Hemophilia A*/drug therapy
Hemophilia A*/diagnosis
Aged, 80 and over ; Humans ; Male ; Chronic Disease ; Factor VIII ; Recurrence ; RNA, Viral ; SARS-CoV-2 ; von Willebrand Factor
SCR Disease Name:: Factor 8 deficiency, acquired

Czasopismo naukowe

na półce

Pełny tekst Szczegóły

Skocz do pozycji: 8.

Tytuł:: Hemophilia A and factor V deficiency in a girl with Turner syndrome: a case report.
Autorzy:: Al Khudari R; Department of Paediatrics, Faculty of Medicine, Damascus University, Damascus, Syria. .
Batesh D; Faculty of Medicine, Damascus University, Damascus, Syria.
Habash R; Faculty of Medicine, Damascus University, Damascus, Syria.
Hamdn O; Division of Hematology and Oncology, Department of Paediatrics, Faculty of Medicine, Damascus University, Damascus, Syria.; Pokaż więcej
Źródło:: Journal of medical case reports [J Med Case Rep] 2023 Nov 18; Vol. 17 (1), pp. 480. Date of Electronic Publication: 2023 Nov 18.
Typ publikacji:: Case Reports; Journal Article
MeSH Terms:: Hemophilia A*/complications
Hemophilia A*/genetics
Hemophilia A*/diagnosis
Factor V Deficiency*/complications
Factor V Deficiency*/genetics
Turner Syndrome*/complications
Turner Syndrome*/genetics
Female ; Humans ; Child, Preschool ; Blood Coagulation Factors ; Blood Coagulation Tests

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 9.

Tytuł:: In Utero Cell Treatment of Hemophilia A Mice via Human Amniotic Fluid Mesenchymal Stromal Cell Engraftment.
Autorzy:: Kao YT; Department of Life Sciences, Ph.D. Program in Translational Medicine, National Chung Hsing University, Taichung 402, Taiwan.; Ph.D. Program in Tissue Engineering and Regenerative Medicine, National Health Research Institutes and National Chung Hsing University, Taichung 402, Taiwan.
Yen CC; Department of Internal Medicine, Pulmonary Medicine Section, China Medical University Hospital, and China Medical University, Taichung 404, Taiwan.
Fan HC; Department of Pediatrics, Department of Medical Research, Tungs' Taichung Metroharbor Hospital, Wuchi, Taichung 435, Taiwan.; Department of Rehabilitation, Jen-Teh Junior College of Medicine, Miaoli 356, Taiwan.
Chen JK; Ph.D. Program in Tissue Engineering and Regenerative Medicine, National Health Research Institutes and National Chung Hsing University, Taichung 402, Taiwan.; Institute of Biomedical Engineering and Nanomedicine, National Health Research Institutes, Miaoli 350, Taiwan.
Chen MS; Department of Anesthesiology, Ditmanson Medical Foundation Chia-Yi Christion Hospital, Chia-Yi 600, Taiwan.
Lan YW; Division of Pulmonary Biology, Cincinnati Children's Hospital Medical Center, University of Cincinnati, Cincinnati, OH 45237, USA.
Yang SH; Department of Physiology, Institute of Basic Medical Sciences, National Cheng Kung University, Tainan 70101, Taiwan.
Chen CM; Department of Life Sciences, Ph.D. Program in Translational Medicine, National Chung Hsing University, Taichung 402, Taiwan.; Ph.D. Program in Tissue Engineering and Regenerative Medicine, National Health Research Institutes and National Chung Hsing University, Taichung 402, Taiwan.; The iEGG and Animal Biotechnology Center, National Chung Hsing University, Taichung 402, Taiwan.; Rong Hsing Research Center for Translational Medicine, National Chung Hsing University, Taichung 402, Taiwan.; Pokaż więcej
Źródło:: International journal of molecular sciences [Int J Mol Sci] 2023 Nov 16; Vol. 24 (22). Date of Electronic Publication: 2023 Nov 16.
Typ publikacji:: Journal Article
MeSH Terms:: Hemophilia A*/genetics
Hemophilia A*/therapy
Hemostatics*/metabolism
Mesenchymal Stem Cells*/metabolism
Pregnancy ; Female ; Humans ; Mice ; Animals ; Infant ; Amniotic Fluid/metabolism ; Factor VIII/genetics ; Factor VIII/metabolism ; Mice, Knockout

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 10.

Tytuł:: Adherence tool for prophylactic haemophilia treatment in adult and adolescent patients: A systematic review and meta-analysis protocol.
Autorzy:: Mokhtar FM; Department of Clinical Pharmacy and Pharmacy Practice, Faculty of Pharmacy, University Malaya, Kuala Lumpur, Malaysia.
Rajakumar S; Jeffery Cheah School of Medicine and Health Sciences, Monash University Malaysia, Subang Jaya, Malaysia.
Zaman Huri H; Department of Clinical Pharmacy and Pharmacy Practice, Faculty of Pharmacy, University Malaya, Kuala Lumpur, Malaysia.; Pokaż więcej
Źródło:: PloS one [PLoS One] 2023 Dec 14; Vol. 18 (12), pp. e0289815. Date of Electronic Publication: 2023 Dec 14 (Print Publication: 2023).
Typ publikacji:: Journal Article
MeSH Terms:: Hemophilia A*/drug therapy
Hemophilia A*/prevention & control
Hemophilia B*/drug therapy
Male ; Adult ; Humans ; Adolescent ; Systematic Reviews as Topic ; Meta-Analysis as Topic ; Hemorrhage/prevention & control ; Hemorrhage/drug therapy ; Blood Coagulation Factors/therapeutic use ; Review Literature as Topic

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 11.

Tytuł:: Total hip and knee arthroplasty in HIV- and HCV-positive hemophilia patients: short term follow-up of 14 patients.
Autorzy:: Wang Z; Shi's Center of Orthopedics and Traumatology, Shuguang Hospital, Shanghai University of Traditional Chinese Medicine, Shanghai, China.; The First Affiliated Hospital of Zhejiang Chinese Medical University (Zhejiang Provincial Hospital of Chinese Medicine), Hangzhou, Zhejiang, China.
Gu Y; Translational Medical Innovation Center, Zhangjiagang TCM Hospital Affiliated to Nanjing University of Chinese Medicine, Zhangjiagang, Jiangsu, China.; Department of Orthopedics, Zhangjiagang TCM Hospital, Nanjing University of Chinese Medicine, Zhangjiagang, Jiangsu, China.; The First Affiliated Hospital of Zhejiang Chinese Medical University (Zhejiang Provincial Hospital of Chinese Medicine), Hangzhou, Zhejiang, China.
Wang R; Guanghua Clinical Medical College, Shanghai University of Traditional Chinese Medicine, Shanghai, China.; The First Affiliated Hospital of Zhejiang Chinese Medical University (Zhejiang Provincial Hospital of Chinese Medicine), Hangzhou, Zhejiang, China.
Xiang S; The First Affiliated Hospital of Zhejiang Chinese Medical University (Zhejiang Provincial Hospital of Chinese Medicine), Hangzhou, Zhejiang, China.
Jin Z; The First Affiliated Hospital of Zhejiang Chinese Medical University (Zhejiang Provincial Hospital of Chinese Medicine), Hangzhou, Zhejiang, China.
Tong P; The First Affiliated Hospital of Zhejiang Chinese Medical University (Zhejiang Provincial Hospital of Chinese Medicine), Hangzhou, Zhejiang, China.
Lv S; The First Affiliated Hospital of Zhejiang Chinese Medical University (Zhejiang Provincial Hospital of Chinese Medicine), Hangzhou, Zhejiang, China. .
Liu X; The First Affiliated Hospital of Zhejiang Chinese Medical University (Zhejiang Provincial Hospital of Chinese Medicine), Hangzhou, Zhejiang, China. .; Pokaż więcej
Źródło:: BMC musculoskeletal disorders [BMC Musculoskelet Disord] 2023 Dec 06; Vol. 24 (1), pp. 946. Date of Electronic Publication: 2023 Dec 06.
Typ publikacji:: Journal Article
MeSH Terms:: Arthroplasty, Replacement, Knee*/adverse effects
Arthroplasty, Replacement, Knee*/methods
Hemophilia A*/complications
Hemophilia A*/epidemiology
Hemophilia A*/surgery
Arthritis*
Hepatitis C*/complications
Hepatitis C*/surgery
HIV Infections*/complications
HIV Infections*/epidemiology
HIV Infections*/surgery
Humans ; Knee Joint/surgery ; Follow-Up Studies ; Treatment Outcome ; Retrospective Studies

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 12.

Tytuł:: Expert opinion paper on the treatment of hemophilia a with emicizumab.
Autorzy:: López-Jaime FJ; Unidad de Hemostasia y Trombosis, Hospital Universitario Regional de Málaga, IBIMA, Málaga, Spain.
Benítez O; Departamento de Hematología Experimental, VHIO Vall d'Hebron Instituto de Oncología, Hospital Universitario Vall d'Hebron, Barcelona, Spain.; Departamento de Medicina, Universidad Autónoma de Barcelona, Barcelona, Spain.
Díaz Jordán BL; Servicio de Hematología y Hemoterapia, Hospital General de Valdepeñas, Valdepeñas, Spain.
Montaño A; Unidad de Hemostasia y Trombosis, Hospital Universitario Regional de Málaga, IBIMA, Málaga, Spain.; Universidad de Salamanca, Salamanca, Spain.
Coll J; Servicio de Hematología, Complejo Hospitalario de Navarra, Pamplona, Spain.
Quintana París L; Servicio de Hematología, Hospital Universitario de Gran Canaria Dr. Negrín, Gran Canaria, Spain.
Gómez-Del Castillo Solano MDC; Unidad de Trombosis y hemostasia, Complejo Hospitalario Universitario A Coruña, A Coruña, Spain.; Pokaż więcej
Źródło:: Hematology (Amsterdam, Netherlands) [Hematology] 2023 Dec; Vol. 28 (1), pp. 2166334.
Typ publikacji:: Review; Journal Article
MeSH Terms:: Antibodies, Bispecific*/therapeutic use
Hemophilia A*/drug therapy
Humans ; Infant, Newborn ; Factor VIII/therapeutic use ; Hemorrhage/drug therapy ; Hemorrhage/etiology ; Hemorrhage/prevention & control

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 13.

Tytuł:: Cost-effectiveness analysis of low-dose prophylaxis versus on-demand treatment for moderate-to-severe hemophilia A in India.
Autorzy:: Seth T; Department of Hematology, AIIMS, New Delhi, India.
Garg K; Department of Pediatric Medicine, SMS Medical College, Jaipur, India.
Mandal PK; Department of Hematology, NRS Medical College, Kolkata, India.
Datta A; Department of Medicine, Assam Medical College and Hospital, Dibrugarh, India.
Verma S; Department of Clinical Hematology, King George's Medical University, Lucknow, India.
Hanagavadi S; Department of Pathology, JJM Medical College, Davangere, India.
Thota UR; Department of Pediatrics, Osmania Medical College, Hyderabad, India.; Pokaż więcej
Źródło:: Hematology (Amsterdam, Netherlands) [Hematology] 2023 Dec; Vol. 28 (1), pp. 2277497. Date of Electronic Publication: 2023 Nov 07.
Typ publikacji:: Journal Article; Review
MeSH Terms:: Hemophilia A*
Joint Diseases*/drug therapy
Adult ; Humans ; Child ; Cost-Effectiveness Analysis ; Prospective Studies ; Cost-Benefit Analysis ; Factor VIII/therapeutic use

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 14.

Tytuł:: Skeletal complications in patients with hemophilia: a single-center experience.
Autorzy:: Bordbar M; Hematology Research Center, Shiraz University of Medical Sciences, Shiraz, Iran.
Beigipour R; Pediatrics Department, Shiraz Medical School, Shiraz University of Medical Sciences, Shiraz, Iran.
Tahami M; Bone and Joint Disease Research Center, Shiraz University of Medical Sciences, Shiraz, Iran.
Zekavat OR; Hematology Research Center, Shiraz University of Medical Sciences, Shiraz, Iran.
Haghpanah S; Hematology Research Center, Shiraz University of Medical Sciences, Shiraz, Iran.
Moshfeghinia R; Student Research Committee, Shiraz University of Medical Sciences, Shiraz, Iran. .; Pokaż więcej
Źródło:: Journal of orthopaedic surgery and research [J Orthop Surg Res] 2023 Nov 29; Vol. 18 (1), pp. 907. Date of Electronic Publication: 2023 Nov 29.
Typ publikacji:: Journal Article
MeSH Terms:: Hemophilia A*/complications
Hemophilia A*/epidemiology
Hemophilia B*/complications
Hemophilia B*/epidemiology
Hepatitis*/complications
Humans ; Adult ; Hemarthrosis/diagnosis ; Hemarthrosis/etiology ; Hemarthrosis/prevention & control ; Cross-Sectional Studies ; Hemorrhage

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 15.

Tytuł:: The frequency of complications in a cohort of patients diagnosed with hemophilia A and hemophilia B receiving prophylactic treatment in Colombia: A retrospective noninterventional study.
Autorzy:: Machado Alba JE; Grupo de Investigación en Farmacoepidemiología y Farmacovigilancia, Universidad Tecnológica de Pereira-Audifarma S.A, Pereira, Colombia.
Wilches-Gutierrez JD; IPS Especializada, Bogotá, Colombia.
Arias-Osorio DR; IPS Especializada, Bogotá, Colombia.
Reyes JM; Pfizer Colombia, Bogotá, Colombia.
Nakandakari ML; Pfizer Colombia, Bogotá, Colombia.
Ospina-Arzuaga HD; Grupo de Investigación en Farmacoepidemiología y Farmacovigilancia, Universidad Tecnológica de Pereira-Audifarma S.A, Pereira, Colombia.
Gaviria-Mendoza A; Grupo de Investigación en Farmacoepidemiología y Farmacovigilancia, Universidad Tecnológica de Pereira-Audifarma S.A, Pereira, Colombia.; Grupo de Investigación en Biomedicina, Fundación Universitaria Autónoma de las Américas, Pereira, Colombia.
Castaño-Gamboa N; Pfizer Colombia, Bogotá, Colombia.
Valladales-Restrepo LF; Grupo de Investigación en Farmacoepidemiología y Farmacovigilancia, Universidad Tecnológica de Pereira-Audifarma S.A, Pereira, Colombia.; Grupo de Investigación en Biomedicina, Fundación Universitaria Autónoma de las Américas, Pereira, Colombia.
Machado-Duque ME; Grupo de Investigación en Farmacoepidemiología y Farmacovigilancia, Universidad Tecnológica de Pereira-Audifarma S.A, Pereira, Colombia.; Grupo de Investigación en Biomedicina, Fundación Universitaria Autónoma de las Américas, Pereira, Colombia.; Pokaż więcej
Źródło:: PloS one [PLoS One] 2023 Nov 27; Vol. 18 (11), pp. e0286187. Date of Electronic Publication: 2023 Nov 27 (Print Publication: 2023).
Typ publikacji:: Journal Article
MeSH Terms:: Hemophilia A*/complications
Hemophilia A*/drug therapy
Hemophilia A*/epidemiology
Hemophilia B*/complications
Hemophilia B*/drug therapy
Hemophilia B*/epidemiology
Humans ; Male ; Child ; Adolescent ; Young Adult ; Adult ; Retrospective Studies ; Colombia/epidemiology ; Factor VIII/therapeutic use ; Hemorrhage/etiology ; Hemorrhage/complications

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 16.

Tytuł:: Physical therapy for end-stage hemophilic arthropathy: a case report.
Autorzy:: Gao ZZ; Department of Rehabilitation Medicine, The First Affiliated Hospital of Zhejiang Chinese Medical University (Zhejiang Provincial Hospital of Chinese Medicine), Hangzhou, Zhejiang, 310006, China.
Yang H; Department of Rehabilitation Medicine, The First Affiliated Hospital of Zhejiang Chinese Medical University (Zhejiang Provincial Hospital of Chinese Medicine), Hangzhou, Zhejiang, 310006, China.
Liu WB; Department of Hematology, The First Affiliated Hospital of Zhejiang Chinese Medical University (Zhejiang Provincial Hospital of Chinese Medicine), Hangzhou, Zhejiang, 310006, China.
Xu C; Department of Rehabilitation Medicine, The First Affiliated Hospital of Zhejiang Chinese Medical University (Zhejiang Provincial Hospital of Chinese Medicine), Hangzhou, Zhejiang, 310006, China.
Xiang SC; Department of Rehabilitation Medicine, The First Affiliated Hospital of Zhejiang Chinese Medical University (Zhejiang Provincial Hospital of Chinese Medicine), Hangzhou, Zhejiang, 310006, China.
Wang LC; Department of Rehabilitation Medicine, The First Affiliated Hospital of Zhejiang Chinese Medical University (Zhejiang Provincial Hospital of Chinese Medicine), Hangzhou, Zhejiang, 310006, China.
Mao YJ; Department of Rehabilitation Medicine, The First Affiliated Hospital of Zhejiang Chinese Medical University (Zhejiang Provincial Hospital of Chinese Medicine), Hangzhou, Zhejiang, 310006, China. .; Pokaż więcej
Źródło:: BMC musculoskeletal disorders [BMC Musculoskelet Disord] 2023 Nov 27; Vol. 24 (1), pp. 916. Date of Electronic Publication: 2023 Nov 27.
Typ publikacji:: Case Reports; Journal Article
MeSH Terms:: Hemophilia A*/complications
Hemophilia A*/therapy
Arthritis*
Joint Diseases*/complications
Joint Diseases*/diagnostic imaging
Male ; Young Adult ; Humans ; Physical Therapy Modalities

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 17.

Tytuł:: Key Genes of the Immune System and Predisposition to Acquired Hemophilia A: Evidence from a Spanish Cohort of 49 Patients Using Next-Generation Sequencing.
Autorzy:: Pardos-Gea J; Systemic Autoimmune Diseases Unit, Department of Internal Medicine, Vall d'Hebron University Hospital, 08035 Barcelona, Spain.
Martin-Fernandez L; Congenital Coagulopathies Laboratory, Blood and Tissue Bank, 08005 Barcelona, Spain.; Transfusional Medicine Group, Vall d'Hebron Research Institute, Autonomous University of Barcelona (VHIR-UAB), 08035 Barcelona, Spain.
Closa L; Transfusional Medicine Group, Vall d'Hebron Research Institute, Autonomous University of Barcelona (VHIR-UAB), 08035 Barcelona, Spain.; Histocompatibility and Immunogenetics Laboratory, Blood and Tissue Bank, 08005 Barcelona, Spain.
Ferrero A; Hematology Service, Arnau de Vilanova University Hospital, 25198 Lleida, Spain.
Marzo C; Hematology Service, Arnau de Vilanova University Hospital, 25198 Lleida, Spain.
Rubio-Rivas M; Department of Internal Medicine, Bellvitge University Hospital, Bellvitge Biomedical Research Institute (IDIBELL), University of Barcelona, L'Hospitalet de Llobregat, 08908 Barcelona, Spain.
Mitjavila F; Department of Internal Medicine, Bellvitge University Hospital, Bellvitge Biomedical Research Institute (IDIBELL), University of Barcelona, L'Hospitalet de Llobregat, 08908 Barcelona, Spain.
González-Porras JR; Department of Hematology, Complejo Asistencial Universitario de Salamanca (CAUSA), Instituto de Investigación Biomedica de Salamanca (IBSAL), Facultad de Medicina, Universidad de Salamanca (USAL), 37007 Salamanca, Spain.
Bastida JM; Department of Hematology, Complejo Asistencial Universitario de Salamanca (CAUSA), Instituto de Investigación Biomedica de Salamanca (IBSAL), Facultad de Medicina, Universidad de Salamanca (USAL), 37007 Salamanca, Spain.
Mateo J; Thrombosis and Hemostasis Unit, Sant Pau Campus Salut Barcelona, 08025 Barcelona, Spain.
Carrasco M; Thrombosis and Hemostasis Unit, Sant Pau Campus Salut Barcelona, 08025 Barcelona, Spain.
Bernardo Á; Hematology Service, Central University Hospital of Asturias, 33011 Oviedo, Spain.
Astigarraga I; Department of Pediatrics, Biobizkaia Health Research Institute, Hospital Universitario Cruces, University of the Basque Country UPV/EHU, 48903 Barakaldo, Spain.
Aguinaco R; Hematology Service, University Hospital Joan XXIII, 43002 Tarragona, Spain.
Corrales I; Congenital Coagulopathies Laboratory, Blood and Tissue Bank, 08005 Barcelona, Spain.; Transfusional Medicine Group, Vall d'Hebron Research Institute, Autonomous University of Barcelona (VHIR-UAB), 08035 Barcelona, Spain.; Centro de Investigación Biomédica en Red de Enfermedades Cardiovasculares (CIBERCV), Instituto Carlos III (ISCIII), 28029 Madrid, Spain.
Garcia-Martínez I; Congenital Coagulopathies Laboratory, Blood and Tissue Bank, 08005 Barcelona, Spain.; Transfusional Medicine Group, Vall d'Hebron Research Institute, Autonomous University of Barcelona (VHIR-UAB), 08035 Barcelona, Spain.
Vidal F; Congenital Coagulopathies Laboratory, Blood and Tissue Bank, 08005 Barcelona, Spain.; Transfusional Medicine Group, Vall d'Hebron Research Institute, Autonomous University of Barcelona (VHIR-UAB), 08035 Barcelona, Spain.; Centro de Investigación Biomédica en Red de Enfermedades Cardiovasculares (CIBERCV), Instituto Carlos III (ISCIII), 28029 Madrid, Spain.; Pokaż więcej
Źródło:: International journal of molecular sciences [Int J Mol Sci] 2023 Nov 15; Vol. 24 (22). Date of Electronic Publication: 2023 Nov 15.
Typ publikacji:: Journal Article
MeSH Terms:: Hemophilia A*/genetics
Humans ; Genotype ; Haplotypes/genetics ; Alleles ; Gene Frequency ; High-Throughput Nucleotide Sequencing ; Immune System ; Genetic Predisposition to Disease
SCR Disease Name:: Factor 8 deficiency, acquired

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 18.

Tytuł:: Risk of low bone mineral density in patients with haemophilia: a systematic review and meta-analysis.
Autorzy:: Zhou H; Zhejiang Chinese Medical University, Hangzhou, Zhejiang Province, China.
Chen L; Zhejiang Chinese Medical University, Hangzhou, Zhejiang Province, China.
Su H; Zhejiang Chinese Medical University, Hangzhou, Zhejiang Province, China.
Chen G; The First Affiliated Hospital of Zhejiang Chinese Medical University (Zhejiang Provincial Hospital of Chinese Medicine), Hangzhou, Zhejiang Province, China. .
Tong P; The First Affiliated Hospital of Zhejiang Chinese Medical University (Zhejiang Provincial Hospital of Chinese Medicine), Hangzhou, Zhejiang Province, China. .; Pokaż więcej
Źródło:: Journal of orthopaedic surgery and research [J Orthop Surg Res] 2024 Jan 11; Vol. 19 (1), pp. 52. Date of Electronic Publication: 2024 Jan 11.
Typ publikacji:: Journal Article; Meta-Analysis; Systematic Review
MeSH Terms:: Bone Diseases, Metabolic*
Hemophilia A*/complications
Osteoporosis*/complications
Humans ; Bone Density ; Femur Neck

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 19.

Tytuł:: Using theory of change to co-create a programme theory for a telerehabilitation intervention for pain management in people with haemophilia.
Autorzy:: McLaughlin P; Katharine Dormandy Haemophilia Centre and Thrombosis Unit, Royal Free London NHS Foundation Trust, London, UK. .; Department of Academic Haematology, University College, London, UK. .
Hurley M; Kingston University, London, UK.
Chowdary P; Katharine Dormandy Haemophilia Centre and Thrombosis Unit, Royal Free London NHS Foundation Trust, London, UK.; Department of Academic Haematology, University College, London, UK.
Khair K; Haemnet, London, UK.
Smith C; The Haemophilia Society, London, UK.
Stephensen D; School of Medicine, Health and Social Care, Canterbury Christchurch University, Canterbury, Kent, UK.; Pokaż więcej
Źródło:: Orphanet journal of rare diseases [Orphanet J Rare Dis] 2023 Dec 01; Vol. 18 (1), pp. 376. Date of Electronic Publication: 2023 Dec 01.
Typ publikacji:: Journal Article
MeSH Terms:: Telerehabilitation*
Hemophilia A*
Humans ; Pain Management ; Exercise Therapy

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 20.

Tytuł:: Application of peripherally inserted central catheter in immune tolerance induction treatment of children with hemophilia A and accompanying inhibitors in China.
Autorzy:: Wang C; Nursing Department, Beijing Children's Hospital, Capital Medical University, Beijing, People's Republic of China.; National Center for Children's Health, Beijing, People's Republic of China.
Liu G; National Center for Children's Health, Beijing, People's Republic of China.; Beijing Key Laboratory of Pediatric Hematology Oncology, Hematology Center, Beijing, People's Republic of China.; National Key Discipline of Pediatrics, Capital Medical University, Beijing, People's Republic of China.; Ministry of Education, Key Laboratory of Major Diseases in Children, Beijing, People's Republic of China.; Department II of Hematology Center, Haemophilia Comprehensive Care Center, Beijing Children's HospitalCapital Medical University, Beijing, People's Republic of China.
Ding Y; Nursing Department, Beijing Children's Hospital, Capital Medical University, Beijing, People's Republic of China.; National Center for Children's Health, Beijing, People's Republic of China.
Li Z; National Center for Children's Health, Beijing, People's Republic of China.; Beijing Key Laboratory of Pediatric Hematology Oncology, Hematology Center, Beijing, People's Republic of China.; National Key Discipline of Pediatrics, Capital Medical University, Beijing, People's Republic of China.; Ministry of Education, Key Laboratory of Major Diseases in Children, Beijing, People's Republic of China.; Department II of Hematology Center, Haemophilia Comprehensive Care Center, Beijing Children's HospitalCapital Medical University, Beijing, People's Republic of China.
Zhen Y; Nursing Department, Beijing Children's Hospital, Capital Medical University, Beijing, People's Republic of China.; National Center for Children's Health, Beijing, People's Republic of China.
Cui J; Nursing Department, Beijing Children's Hospital, Capital Medical University, Beijing, People's Republic of China.; National Center for Children's Health, Beijing, People's Republic of China.
Yao W; National Center for Children's Health, Beijing, People's Republic of China.; Beijing Key Laboratory of Pediatric Hematology Oncology, Hematology Center, Beijing, People's Republic of China.; National Key Discipline of Pediatrics, Capital Medical University, Beijing, People's Republic of China.; Ministry of Education, Key Laboratory of Major Diseases in Children, Beijing, People's Republic of China.; Department II of Hematology Center, Haemophilia Comprehensive Care Center, Beijing Children's HospitalCapital Medical University, Beijing, People's Republic of China.
Di A; National Center for Children's Health, Beijing, People's Republic of China.; Beijing Key Laboratory of Pediatric Hematology Oncology, Hematology Center, Beijing, People's Republic of China.; National Key Discipline of Pediatrics, Capital Medical University, Beijing, People's Republic of China.; Ministry of Education, Key Laboratory of Major Diseases in Children, Beijing, People's Republic of China.; Department II of Hematology Center, Haemophilia Comprehensive Care Center, Beijing Children's HospitalCapital Medical University, Beijing, People's Republic of China.
Huang K; National Center for Children's Health, Beijing, People's Republic of China.; Beijing Key Laboratory of Pediatric Hematology Oncology, Hematology Center, Beijing, People's Republic of China.; National Key Discipline of Pediatrics, Capital Medical University, Beijing, People's Republic of China.; Ministry of Education, Key Laboratory of Major Diseases in Children, Beijing, People's Republic of China.; Department II of Hematology Center, Haemophilia Comprehensive Care Center, Beijing Children's HospitalCapital Medical University, Beijing, People's Republic of China.
Feng P; Nursing Department, Beijing Children's Hospital, Capital Medical University, Beijing, People's Republic of China.; National Center for Children's Health, Beijing, People's Republic of China.
Wu R; National Center for Children's Health, Beijing, People's Republic of China.; Beijing Key Laboratory of Pediatric Hematology Oncology, Hematology Center, Beijing, People's Republic of China.; National Key Discipline of Pediatrics, Capital Medical University, Beijing, People's Republic of China.; Ministry of Education, Key Laboratory of Major Diseases in Children, Beijing, People's Republic of China.; Department II of Hematology Center, Haemophilia Comprehensive Care Center, Beijing Children's HospitalCapital Medical University, Beijing, People's Republic of China.; Pokaż więcej
Źródło:: Hematology (Amsterdam, Netherlands) [Hematology] 2023 Dec; Vol. 28 (1), pp. 2250601.
Typ publikacji:: Journal Article
MeSH Terms:: Hemophilia A*/therapy
Catheterization, Peripheral*
Child ; Humans ; Quality of Life ; Retrospective Studies ; China ; Immune Tolerance ; Catheters

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Informacja

Wyszukujesz frazę ""hemophilia A"" wg kryterium: Temat

Źródło danych

Ogranicz do:

Ogranicz do bazy

Typ dokumentu

Temat

Wydawca

Publikacja

Język

Rok publikacji